KR100790514B1 - Csf를 유선에서 발현하는 형질전환 복제 돼지 및 그의제조 방법 - Google Patents
Csf를 유선에서 발현하는 형질전환 복제 돼지 및 그의제조 방법 Download PDFInfo
- Publication number
- KR100790514B1 KR100790514B1 KR1020050078585A KR20050078585A KR100790514B1 KR 100790514 B1 KR100790514 B1 KR 100790514B1 KR 1020050078585 A KR1020050078585 A KR 1020050078585A KR 20050078585 A KR20050078585 A KR 20050078585A KR 100790514 B1 KR100790514 B1 KR 100790514B1
- Authority
- KR
- South Korea
- Prior art keywords
- csf
- hgm
- cells
- cloned
- somatic cells
- Prior art date
Links
- 230000009261 transgenic effect Effects 0.000 title claims abstract description 32
- 108090000623 proteins and genes Proteins 0.000 title claims description 51
- 238000000034 method Methods 0.000 title abstract description 30
- 235000013336 milk Nutrition 0.000 title description 5
- 239000008267 milk Substances 0.000 title description 5
- 210000004080 milk Anatomy 0.000 title description 5
- 108010071942 Colony-Stimulating Factors Proteins 0.000 claims abstract description 36
- 102000007644 Colony-Stimulating Factors Human genes 0.000 claims abstract description 34
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 210000001728 clone cell Anatomy 0.000 claims description 6
- 210000001082 somatic cell Anatomy 0.000 abstract description 34
- 235000013601 eggs Nutrition 0.000 abstract description 31
- 241000282887 Suidae Species 0.000 abstract description 21
- 210000005075 mammary gland Anatomy 0.000 abstract description 21
- 238000004519 manufacturing process Methods 0.000 abstract description 20
- 239000013604 expression vector Substances 0.000 abstract description 19
- 239000002671 adjuvant Substances 0.000 abstract description 3
- 238000012258 culturing Methods 0.000 abstract description 3
- 230000032696 parturition Effects 0.000 abstract description 3
- 108091033319 polynucleotide Proteins 0.000 abstract description 3
- 239000002157 polynucleotide Substances 0.000 abstract description 3
- 102000040430 polynucleotide Human genes 0.000 abstract description 3
- 230000004481 post-translational protein modification Effects 0.000 abstract description 3
- 208000032839 leukemia Diseases 0.000 abstract description 2
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 39
- 235000018102 proteins Nutrition 0.000 description 16
- 238000010367 cloning Methods 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 15
- 239000013598 vector Substances 0.000 description 14
- 210000003754 fetus Anatomy 0.000 description 10
- 102100021943 C-C motif chemokine 2 Human genes 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 9
- 101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 210000004940 nucleus Anatomy 0.000 description 8
- 210000002540 macrophage Anatomy 0.000 description 7
- 230000000392 somatic effect Effects 0.000 description 7
- 102000011632 Caseins Human genes 0.000 description 6
- 238000002105 Southern blotting Methods 0.000 description 6
- 230000004069 differentiation Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 102000004127 Cytokines Human genes 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 5
- 241001045988 Neogene Species 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 244000144972 livestock Species 0.000 description 5
- 101150091879 neo gene Proteins 0.000 description 5
- 210000000287 oocyte Anatomy 0.000 description 5
- 230000035935 pregnancy Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000003757 reverse transcription PCR Methods 0.000 description 5
- 210000000130 stem cell Anatomy 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 235000021247 β-casein Nutrition 0.000 description 5
- 108010076119 Caseins Proteins 0.000 description 4
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 4
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 4
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 4
- 108010002386 Interleukin-3 Proteins 0.000 description 4
- 102100039064 Interleukin-3 Human genes 0.000 description 4
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 210000001744 T-lymphocyte Anatomy 0.000 description 4
- 229940047120 colony stimulating factors Drugs 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 102000046157 human CSF2 Human genes 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 210000002257 embryonic structure Anatomy 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 2
- 101000910039 Bos taurus Alpha-S1-casein Proteins 0.000 description 2
- 101000741065 Bos taurus Beta-casein Proteins 0.000 description 2
- 101001008231 Bos taurus Beta-lactoglobulin Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 101150112014 Gapdh gene Proteins 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 102000000589 Interleukin-1 Human genes 0.000 description 2
- 108010002352 Interleukin-1 Proteins 0.000 description 2
- 108010002586 Interleukin-7 Proteins 0.000 description 2
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 2
- 102000008192 Lactoglobulins Human genes 0.000 description 2
- 102100033374 Leukotriene B4 receptor 1 Human genes 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 101710087237 Whey acidic protein Proteins 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 230000020411 cell activation Effects 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 210000003714 granulocyte Anatomy 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229960002725 isoflurane Drugs 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 208000004235 neutropenia Diseases 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 239000012096 transfection reagent Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- CNNSWSHYGANWBM-UHFFFAOYSA-N 6-chloro-2,3-dimethylquinoxaline Chemical compound C1=C(Cl)C=C2N=C(C)C(C)=NC2=C1 CNNSWSHYGANWBM-UHFFFAOYSA-N 0.000 description 1
- 206010000830 Acute leukaemia Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 101100275473 Caenorhabditis elegans ctc-3 gene Proteins 0.000 description 1
- 101100129922 Caenorhabditis elegans pig-1 gene Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 101100520057 Drosophila melanogaster Pig1 gene Proteins 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001033279 Homo sapiens Interleukin-3 Proteins 0.000 description 1
- 101001017968 Homo sapiens Leukotriene B4 receptor 1 Proteins 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 1
- 101710144554 Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108010002616 Interleukin-5 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090000093 Leukotriene B4 receptors Proteins 0.000 description 1
- 208000035752 Live birth Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 210000001109 blastomere Anatomy 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 238000010322 bone marrow transplantation Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- JVHIPYJQMFNCEK-UHFFFAOYSA-N cytochalasin Natural products N1C(=O)C2(C(C=CC(C)CC(C)CC=C3)OC(C)=O)C3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 JVHIPYJQMFNCEK-UHFFFAOYSA-N 0.000 description 1
- ZMAODHOXRBLOQO-UHFFFAOYSA-N cytochalasin-A Natural products N1C(=O)C23OC(=O)C=CC(=O)CCCC(C)CC=CC3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 ZMAODHOXRBLOQO-UHFFFAOYSA-N 0.000 description 1
- 230000001210 effect on neutrophils Effects 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 210000001733 follicular fluid Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 102000035122 glycosylated proteins Human genes 0.000 description 1
- 108091005608 glycosylated proteins Proteins 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 210000004565 granule cell Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 239000003407 interleukin 1 receptor blocking agent Substances 0.000 description 1
- 229940076264 interleukin-3 Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004216 mammary stem cell Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003593 megakaryocyte Anatomy 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 210000004508 polar body Anatomy 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000009597 pregnancy test Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960000160 recombinant therapeutic protein Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 210000004340 zona pellucida Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0273—Cloned vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/108—Swine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- C12N2015/8518—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biodiversity & Conservation Biology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (9)
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 수탁번호 KCLRF-BP-00115로 기탁된 CSF(colony stimulating factor, 세포 집락 자극 인자) 단백질을 발현하는 형질전환 돼지 클론 세포주.
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050078585A KR100790514B1 (ko) | 2005-08-26 | 2005-08-26 | Csf를 유선에서 발현하는 형질전환 복제 돼지 및 그의제조 방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050078585A KR100790514B1 (ko) | 2005-08-26 | 2005-08-26 | Csf를 유선에서 발현하는 형질전환 복제 돼지 및 그의제조 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070024069A KR20070024069A (ko) | 2007-03-02 |
KR100790514B1 true KR100790514B1 (ko) | 2008-01-02 |
Family
ID=38098842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050078585A KR100790514B1 (ko) | 2005-08-26 | 2005-08-26 | Csf를 유선에서 발현하는 형질전환 복제 돼지 및 그의제조 방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100790514B1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101324345B1 (ko) * | 2011-04-04 | 2013-10-31 | 한화엘앤씨 주식회사 | Ho-1 유전자를 발현하는 형질전환 돼지 및 이의 용도 |
KR101938956B1 (ko) | 2016-05-31 | 2019-01-15 | 제주대학교 산학협력단 | 신경세포 특이적으로 발현하는 돼지 Thy1 유전자 프로모터 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010077563A (ko) * | 2000-02-03 | 2001-08-20 | 김태윤 | hGM-CSF의 제조방법 |
US6635474B1 (en) * | 1998-09-11 | 2003-10-21 | Hanmi Pharm Co., Ltd | Mammary gland tissue-specific expression system using β-casein promoter site of Korean native goat |
KR20040064507A (ko) * | 2003-01-13 | 2004-07-19 | 김남형 | 돼지의 수정란 체외 배양방법 |
-
2005
- 2005-08-26 KR KR1020050078585A patent/KR100790514B1/ko active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6635474B1 (en) * | 1998-09-11 | 2003-10-21 | Hanmi Pharm Co., Ltd | Mammary gland tissue-specific expression system using β-casein promoter site of Korean native goat |
KR20010077563A (ko) * | 2000-02-03 | 2001-08-20 | 김태윤 | hGM-CSF의 제조방법 |
KR20040064507A (ko) * | 2003-01-13 | 2004-07-19 | 김남형 | 돼지의 수정란 체외 배양방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20070024069A (ko) | 2007-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Krimpenfort et al. | Generation of transgenic dairy cattle using ‘in vitro’embryo production | |
RU2216592C2 (ru) | Способ получения эмбрионов животных и способ выращивания животного из эмбрионов | |
JP4153878B2 (ja) | Gt遺伝子が除去された複製豚及びその生産方法 | |
CN101591672B (zh) | 一种包含hBD3乳腺特异性表达载体的重组牛胎儿成纤维细胞 | |
KR100790514B1 (ko) | Csf를 유선에서 발현하는 형질전환 복제 돼지 및 그의제조 방법 | |
KR100769291B1 (ko) | 유선 특이적 인간 에리트로포이에틴 발현 벡터, 이를이용한 형질전환 동물 및 이를 이용한 인간에리트로포이에틴의 생산 방법 | |
KR101890978B1 (ko) | 알츠하이머 질환 모델용 형질전환 돼지 및 이의 용도 | |
CN111073900B (zh) | 一种提高猪克隆胚胎发育效率的方法 | |
KR100905709B1 (ko) | hGM―CSF를 생산하는 형질전환된 복제 산양 및 이의제조방법 | |
Park et al. | Production of transgenic recloned piglets harboring the human granulocyte-macrophage colony stimulating factor (hGM-CSF) gene from porcine fetal fibroblasts by nuclear transfer | |
KR101763343B1 (ko) | 체세포 또는 줄기세포의 핵 이식을 이용한 복제개의 생산방법 | |
KR101276801B1 (ko) | sTNFR1-Fc 유전자를 발현하는 형질전환 돼지 및 이의 용도 | |
KR100479704B1 (ko) | 녹색 형광단백질을 발현하는 형질전환 돼지의 제조 방법 | |
US7351876B2 (en) | Efficient nuclear transfer with primordial gametes | |
KR101832485B1 (ko) | 목적유전자를 조건적으로 발현하는 복제된 개과동물의 생산방법 | |
JP5771240B2 (ja) | 免疫不全ブタ | |
KR20090115081A (ko) | 개과 동물의 복제 생산 방법 | |
KR20060106590A (ko) | 자연살해 세포의 활성을 억제하기 위한 hla-g 유전자를발현하는 형질 전환 복제 돼지 및 그의 제조 방법 | |
AU747070B2 (en) | Efficient nuclear transfer using primordial germ cells | |
KR20230092097A (ko) | 돼지 GGTA1, CMAH, β4GalNT2 및 CD40 유전자가 결손된 이종장기이식을 위한 형질전환 복제돼지 및 이의 제조방법 | |
KR100827324B1 (ko) | hGM-CSF 유전자로 형질전환된 산양 체세포의 핵이이식된 복제수정란 및 이의 제조방법 | |
Lian et al. | Application status of genome-editing tools in sheep and goats | |
WO2005028655A1 (fr) | Procede d'augmentation de l'efficacite d'un animal transgenique | |
RU2157846C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ТРАНСГЕННОГО ЖИВОТНОГО, ЭКСПРЕССИРУЮЩЕГО В МОЛОЧНОЙ ЖЕЛЕЗЕ ГРАНУЛОЦИТАРНЫЙ КОЛОНИЕСТИМУЛИРУЮЩИЙ ФАКТОР ЧЕЛОВЕКА И ГИБРИДНЫЙ ГЕН h-GM-1 ДЛЯ ОСУЩЕСТВЛЕНИЯ СПОСОБА | |
RU2390562C2 (ru) | Способ получения трансгенных млекопитающих, которые продуцируют экзогенные белки в молоке, и трансгенные млекопитающие, полученные таким способом |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20111226 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130321 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140807 Year of fee payment: 7 |
|
R401 | Registration of restoration | ||
FPAY | Annual fee payment |
Payment date: 20141224 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20151221 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20161221 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20171106 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20181031 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20191021 Year of fee payment: 13 |